Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters.
Mol Ther Nucleic Acids. 2017 Sep 15;8:300-316. doi: 10.1016/j.omtn.2017.07.002. Epub 2017 Jul 8.
Mol Ther Nucleic Acids. 2017.
PMID: 28918031
Free PMC article.
Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal Carcinoma.
Hazini A, Pryshliak M, Brückner V, Klingel K, Sauter M, Pinkert S, Kurreck J, Fechner H.
Hazini A, et al. Among authors: pryshliak m.
Hum Gene Ther. 2018 Nov;29(11):1301-1314. doi: 10.1089/hum.2018.036. Epub 2018 Jun 20.
Hum Gene Ther. 2018.
PMID: 29739251
Item in Clipboard
Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
Pinkert S, Pryshliak M, Pappritz K, Knoch K, Hazini A, Dieringer B, Schaar K, Dong F, Hinze L, Lin J, Lassner D, Klopfleisch R, Solimena M, Tschöpe C, Kaya Z, El-Shafeey M, Beling A, Kurreck J, Van Linthout S, Klingel K, Fechner H.
Pinkert S, et al. Among authors: pryshliak m.
Cardiovasc Res. 2020 Aug 1;116(10):1756-1766. doi: 10.1093/cvr/cvz259.
Cardiovasc Res. 2020.
PMID: 31598635
Item in Clipboard
Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S, Dieringer B, Klopfleisch R, Savvatis K, Van Linthout S, Pryshliak M, Tschöpe C, Klingel K, Kurreck J, Beling A, Fechner H.
Pinkert S, et al. Among authors: pryshliak m.
Circ Heart Fail. 2019 Nov;12(11):e005250. doi: 10.1161/CIRCHEARTFAILURE.119.005250. Epub 2019 Nov 13.
Circ Heart Fail. 2019.
PMID: 31718319
Item in Clipboard
MiR-375-mediated suppression of engineered coxsackievirus B3 in pancreatic cells.
Pryshliak M, Hazini A, Knoch K, Dieringer B, Tolksdorf B, Solimena M, Kurreck J, Pinkert S, Fechner H.
Pryshliak M, et al.
FEBS Lett. 2020 Feb;594(4):763-775. doi: 10.1002/1873-3468.13647. Epub 2019 Nov 7.
FEBS Lett. 2020.
PMID: 31643074
Free article.
Item in Clipboard
Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H.
Hazini A, Dieringer B, Klingel K, Pryshliak M, Geisler A, Kobelt D, Daberkow O, Kurreck J, Linthout SV, Fechner H.
Hazini A, et al. Among authors: pryshliak m.
Viruses. 2021 Sep 24;13(10):1918. doi: 10.3390/v13101918.
Viruses. 2021.
PMID: 34696348
Free PMC article.
Item in Clipboard
miR-375- and miR-1-Regulated Coxsackievirus B3 Has No Pancreas and Heart Toxicity But Strong Antitumor Efficiency in Colorectal Carcinomas.
Hazini A, Dieringer B, Pryshliak M, Knoch KP, Heimann L, Tolksdorf B, Pappritz K, El-Shafeey M, Solimena M, Beling A, Kurreck J, Klingel K, Fechner H.
Hazini A, et al. Among authors: pryshliak m.
Hum Gene Ther. 2021 Feb;32(3-4):216-230. doi: 10.1089/hum.2020.228. Epub 2021 Jan 22.
Hum Gene Ther. 2021.
PMID: 33481658
Item in Clipboard
Vibrio vulnificus phage PV94 is closely related to temperate phages of V. cholerae and other Vibrio species.
Pryshliak M, Hammerl JA, Reetz J, Strauch E, Hertwig S.
Pryshliak M, et al.
PLoS One. 2014 Apr 14;9(4):e94707. doi: 10.1371/journal.pone.0094707. eCollection 2014.
PLoS One. 2014.
PMID: 24732980
Free PMC article.
Item in Clipboard
Cite
Cite